The
autoimmune disease diagnostics market is
poised to grow by USD 1.94 billion during 2020-2024, progressing at a CAGR of
almost 9% during the forecast period.
The market is driven by the discovery of novel biomarkers leading to
improved autoimmune diagnosis. In addition, the increasing consumer shift
toward direct-to-consumer testing is anticipated to boost the growth of the
autoimmune disease diagnostics market.
There is an increased demand for multiple biomarkers that help in
identifying and evaluating the patient status, disease type, and progression,
and response to therapy for autoimmune diseases. This is compelling vendors and
research institutes to increase their R&D efforts to develop effective
biomarkers for use in autoimmune diseases. The ability to screen an individual
with multiple biomarkers associated with several autoimmune diseases has
enhanced the diagnosis of autoimmune diseases. This is proving to be an added
advantage for physicians in the diagnosis of complex diseases. These factors
are significantly influencing the growth of the global autoimmune diagnostics
market.
Buy 1 Technavio report and get the
second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Autoimmune Disease Diagnostics Companies:
Abbott Laboratories
Abbott Laboratories operates its business through segments such as
Established Pharmaceuticals Products, Nutritional Products, Diagnostic
Products, and Medical Devices. ARCHITECT i2000SR and ARCHITECT i4000SR are the
key offerings of the company.
bioMérieux SA
bioMérieux SA operates its business through segments such as Clinical
applications and Industrial applications. VIDAS beta2 Microglobulin is the key
offering of the company. It is an automated test for the quantitative
measurement of beta2 microglobulin in human serum or plasma and urine using the
ELFA technique.
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. operates its business through segments such as
Life Science and Clinical Diagnostics. HEp-2 IFA, BioPlex 2200 Celiac IgA,
BioPlex 2200 Anti-CCP, and Anti-CCP EIA are the key offerings of the company.
Danaher Corp.
Danaher Corp. operates its business through segments such as Life
Sciences, Diagnostics, and Environmental & Applied Solutions. UniCel DxI
800 is the key offering of the company. It provides fast and accurate results
with chemiluminescent technology.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. operates its business through segments such as
Pharmaceuticals and Diagnostics. Elecsys Anti-TSHR, Cobas 4000 analyzer series,
and Cobas 8000 modular analyzer series are the key offerings of the company.
No comments:
Post a Comment